BioLineRx Ltd.
For the period ended Mar 23, 2026. Filed Mar 23, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Mar 23, 2026 · Filed Mar 23, 2026
Use the contents to explore the available documents and sections.
BLRX$1.71-3.3%Stored close · as of Nov 6, 2026
Contents
EX-99 · APHEXDA Performance Update
APHEXDA Performance Update
| • | For the full-year 2025, APHEXDA sales were $6.7 million, which provided royalty revenue to the Company of $1.2 million. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.